Latest Updates See All
Has your physician mentioned biosimilars?
FDA-approved medications may offer lower-cost options Approved for use in the United States in 2015…
New study finds insulin rationing incredibly common and incredibly dangerous
More than 1.3 million American adults with diabetes ration their insulin – meaning they skip doses or take less than…
$38,398 for just one shot of a very old cancer med. How can this happen?
Paul Hinds agreed to get a physical at the urging of his new girlfriend. It was a fortunate decision…
From Social Media
Too many patients like Susan can't afford the care they need. Thank you for sharing, Susan. #MyHealthMyVoice
we keep saying we are going to find a cure for cancer but the cure will only be for the rich! That needs to change. Medicare for All!
Patients like Jennine are struggling to afford their care. Have you shared your story? #MyHealthMyVoice
On November 29, the Regence Health Policy Center is hosting a virtual panel discussion, Improving Drug Affordability: The Promise of Biosimilars. Experts will unpack the complexities of the biosimilars landscape, including opportunities and policy solutions to increase update, drive adoption, and provide a pathway to more affordable prescription drugs. The webinar is free and all are invited.
Improving Drug Affordability: The Promise of Biosimilars
www.eventbrite.com
Join the Regence Health Policy Center as we explore the future and promise of biosimilars advancing prescription drug affordability.